{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:03:32Z","timestamp":1740135812163,"version":"3.37.3"},"reference-count":19,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2019,3,21]]},"DOI":"10.1080\/10428194.2018.1516879","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T07:45:00Z","timestamp":1539157500000},"page":"1079-1082","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Response to pembrolizumab and lenalidomide in advanced refractory mycosis fungoides"],"prefix":"10.1080","volume":"60","author":[{"given":"Eric","family":"Fountain","sequence":"first","affiliation":[{"name":"MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haleigh","family":"Mistry","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2735-168X","authenticated-orcid":false,"given":"Preetesh","family":"Jain","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8971-4565","authenticated-orcid":false,"given":"Madeleine","family":"Duvic","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9494-1877","authenticated-orcid":false,"given":"Nathan","family":"Fowler","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3502"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-154609"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-376319"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2015.11.010"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-588236"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2015.05.014"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.3787"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.0004"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.9066"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31266-7"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-600924"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0610"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-525915"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.9789"},{"volume-title":"Pembrolizumab for treatment of relapsed\/refractory mycosis fungoides and sezary syndrome: clinical efficacy in a CITN multicenter phase 2 study. Oral Abstract #181. Paper presented at: ASH 58th Annual Meeting and Exposition; 2016 Dec 3; San Diego, CA.","author":"Khodadoust M","key":"CIT0015"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-775122"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-2-36"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-279893"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-02-0361"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2018.1516879","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T22:25:32Z","timestamp":1597530332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2018.1516879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,3,21]]}},"alternative-id":["10.1080\/10428194.2018.1516879"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2018.1516879","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"type":"print","value":"1042-8194"},{"type":"electronic","value":"1029-2403"}],"subject":[],"published":{"date-parts":[[2018,10,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-06-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}